Insider Selling: BrightSpring Health Services (NASDAQ:BTSG) Insider Sells 235,000 Shares of Stock

Key Points

• Insider Jon Rousseau sold 235,000 shares of BrightSpring Health Services at an average price of $28.78, totaling approximately $6.76 million, reducing his ownership by 17.19%.
• BrightSpring Health Services reported an earnings per share (EPS) of $0.30 for the last quarter, beating estimates of $0.27, and revenue of $3.33 billion, surpassing expectations.
• Several institutional investors have increased their stakes in BrightSpring, with Invesco Ltd. boosting its holdings by 47.7% during the second quarter.

BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report) insider Jon Rousseau sold 235,000 shares of BrightSpring Health Services stock in a transaction on Wednesday, October 22nd. The shares were sold at an average price of $28.78, for a total value of $6,763,300.00. Following the completion of the sale, the insider directly owned 1,131,930 shares of the company's stock, valued at $32,576,945.40. This trade represents a 17.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

BrightSpring Health Services Trading Up 2.1%

Shares of NASDAQ BTSG traded up $0.69 during midday trading on Wednesday, hitting $32.94. The stock had a trading volume of 4,621,568 shares, compared to its average volume of 2,505,810. The company's 50-day simple moving average is $26.66 and its 200 day simple moving average is $22.88. The firm has a market cap of $5.84 billion, a P/E ratio of 54.00, a price-to-earnings-growth ratio of 0.46 and a beta of 2.40. BrightSpring Health Services, Inc. has a fifty-two week low of $14.73 and a fifty-two week high of $33.16. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.76 and a quick ratio of 1.34.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last released its earnings results on Monday, October 20th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.27 by $0.03. The company had revenue of $3.33 billion during the quarter, compared to analysts' expectations of $3.16 billion. BrightSpring Health Services had a return on equity of 11.83% and a net margin of 1.04%. BrightSpring Health Services has set its Q3 2025 guidance at 0.300-0.300 EPS. FY 2025 guidance at EPS. Research analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.

Hedge Funds Weigh In On BrightSpring Health Services

Several institutional investors and hedge funds have recently made changes to their positions in the company. Invesco Ltd. grew its position in shares of BrightSpring Health Services by 47.7% in the second quarter. Invesco Ltd. now owns 9,119,408 shares of the company's stock valued at $215,127,000 after purchasing an additional 2,946,811 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of BrightSpring Health Services by 24.6% in the 1st quarter. Vanguard Group Inc. now owns 6,633,744 shares of the company's stock valued at $120,004,000 after purchasing an additional 1,308,651 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in shares of BrightSpring Health Services by 264.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 5,772,772 shares of the company's stock valued at $104,430,000 after acquiring an additional 4,189,805 shares during the last quarter. Alliancebernstein L.P. lifted its stake in shares of BrightSpring Health Services by 12.1% in the 2nd quarter. Alliancebernstein L.P. now owns 5,450,085 shares of the company's stock valued at $128,568,000 after acquiring an additional 588,642 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its stake in shares of BrightSpring Health Services by 936.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,276,583 shares of the company's stock valued at $53,705,000 after acquiring an additional 2,056,920 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on BTSG shares. Cowen restated a "buy" rating on shares of BrightSpring Health Services in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $30.00 price target on BrightSpring Health Services and gave the company a "buy" rating in a report on Monday, September 8th. Morgan Stanley boosted their price target on BrightSpring Health Services from $25.00 to $32.00 and gave the company an "overweight" rating in a report on Tuesday, October 14th. Mizuho upped their target price on BrightSpring Health Services from $26.00 to $32.00 and gave the stock an "outperform" rating in a report on Friday, October 17th. Finally, Bank of America upped their price objective on BrightSpring Health Services from $27.50 to $31.00 and gave the company a "buy" rating in a research note on Wednesday, September 10th. Ten equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $32.56.

BrightSpring Health Services Company Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.